Zobrazeno 1 - 10
of 417
pro vyhledávání: '"Nebot, N."'
Autor:
Tran-Dinh, A., Neulier, C., Amara, M., Nebot, N., Troché, G., Breton, N., Zuber, B., Cavelot, S., Pangon, B., Bedos, J.P., Merrer, J., Grimaldi, D.
Publikováno v:
In Journal of Hospital Infection November 2018 100(3):e105-e114
Autor:
Soria, J.C. *, Gan, H.K., Blagden, S.P., Plummer, R., Arkenau, H.T., Ranson, M., Evans, T.R.J., Zalcman, G., Bahleda, R., Hollebecque, A., Lemech, C., Dean, E., Brown, J., Gibson, D., Peddareddigari, V., Murray, S., Nebot, N., Mazumdar, J., Swartz, L., Auger, K.R., Fleming, R.A., Singh, R., Millward, M.
Publikováno v:
In Annals of Oncology December 2016 27(12):2268-2274
Autor:
Nebot N; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Won CS; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Muñoz-Couselo E; VHIO - Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Lee DY; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Gasal E; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Bouillaud E; Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Sep; Vol. 10 (9), pp. 1054-1063. Date of Electronic Publication: 2021 May 01.
Autor:
Li, Xumao1 (AUTHOR) lixumao2018@126.com
Publikováno v:
PLoS ONE. 11/6/2024, Vol. 19 Issue 11, p1-17. 17p.
Autor:
Rosa-Jiménez, Carlos1 cjrosa@uma.es, José Márquez-Ballesteros, Maria1 mjmarquez@uma.es, García-Moreno, Alberto E.1 algamor@uma.es, Navas-Carrillo, Daniel1 danielnavas@uma.es
Publikováno v:
Revista INVI. nov2024, Vol. 39 Issue 112, p180-205. 26p.
Autor:
Proctor, W. R., Thakker, D. R., Gnoth, M. J., Han, T., Swift, B., Lee, J. K., Radtke, M., Lang, D., Nebot, N., Brouwer, K. L. R.
Sorafenib is an orally active tyrosine kinase inhibitor used in the treatment of renal and hepatocellular carcinoma. This study was designed to establish whether transport proteins are involved in the hepatic uptake of sorafenib and to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::798b6ba1e281fd85fd05d0fd8adb4179
Autor:
Kieran MW; Harvard Medical School, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts., Geoerger B; Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. birgit.geoerger@gustaveroussy.fr., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, New York., Broniscer A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Hargrave D; UCL Great Ormond Street Institute of Child Health, Pediatric Oncology Unit, London, United Kingdom., Hingorani P; Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona., Aerts I; Institut Curie, PSL Research University, Oncology Center SIREDO, Paris, France., Bertozzi AI; CHU de Toulouse - Pôle Pédiatrique, Toulouse, France., Cohen KJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Hummel TR; Cancer and Blood Disorder Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Shen V; Children's Hospital of Orange County, Orange, California., Bouffet E; The Hospital for Sick Children, University of Toronto, Department of Pediatrics, Toronto, Ontario., Pratilas CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Pearson ADJ; Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, and The Institute of Cancer Research, Sutton, United Kingdom., Tseng L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Nebot N; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Green S; Novartis Pharma AG, Basel, Switzerland., Russo MW; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Whitlock JA; The Hospital for Sick Children, University of Toronto, Department of Pediatrics, Toronto, Ontario.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 15; Vol. 25 (24), pp. 7294-7302. Date of Electronic Publication: 2019 Sep 10.
Autor:
Mak G; Sarah Cannon Research Institute, London, UK.; Cancer Centre, University College London, London, UK., Soria JC; Drug Development Department at Gustave Roussy Cancer Campus, University Paris-Sud, Paris, France., Blagden SP; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.; Department of Oncology, University of Oxford, Oxford, UK., Plummer R; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Fleming RA; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA., Nebot N; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA.; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Zhang J; PAREXEL International, Durham, NC, USA., Mazumdar J; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA.; Chimeron Bio, New York, NY, 10016, USA., Rogan D; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA., Gazzah A; Drug Development Department at Gustave Roussy Cancer Campus, University Paris-Sud, Paris, France., Rizzuto I; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Greystoke A; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Yan L; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA., Tolson J; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA., Auger KR; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, PA, USA., Arkenau HT; Sarah Cannon Research Institute, London, UK. Tobias.Arkenau@HCAHealthcare.co.uk.; Cancer Centre, University College London, London, UK. Tobias.Arkenau@HCAHealthcare.co.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 May; Vol. 120 (10), pp. 975-981. Date of Electronic Publication: 2019 Apr 17.
Autor:
Kieran, M.W., Bouffet, E., Tabori, U., Broniscer, A., Cohen, K., Hansford, J., Geoerger, B., Hingorani, P., Dunkel, I., Russo, M., Tseng, L., Liu, Q., Nebot, N., Whitlock, J., Hargrave, D.
Publikováno v:
In Annals of Oncology 1 October 2016 27 Supplement 6:vi557-vi557